A detailed history of Cora Capital Advisors LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Cora Capital Advisors LLC holds 12,153 shares of OCGN stock, worth $13,611. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,153
Holding current value
$13,611
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$1.18 - $1.98 $14,340 - $24,062
12,153 New
12,153 $18.8 Million

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $243M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Cora Capital Advisors LLC Portfolio

Follow Cora Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cora Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cora Capital Advisors LLC with notifications on news.